180 related articles for article (PubMed ID: 29356985)
1. Neoadjuvant denosumab for the treatment of a sacral osteoblastoma.
Reynolds JJ; Rothenfluh DA; Athanasou N; Wilson S; Kieser DC
Eur Spine J; 2018 Jul; 27(Suppl 3):446-452. PubMed ID: 29356985
[TBL] [Abstract][Full Text] [Related]
2. The Use of Denosumab in Osteoblastoma of the Metacarpal.
Kooner P; Ferguson P
J Hand Surg Am; 2019 Nov; 44(11):994.e1-994.e6. PubMed ID: 30910238
[TBL] [Abstract][Full Text] [Related]
3. Osteoblastoma of the sacrum: report of 18 cases and analysis of the literature.
Ruggieri P; Huch K; Mavrogenis AF; Merlino B; Angelini A
Spine (Phila Pa 1976); 2014 Jan; 39(2):E97-E103. PubMed ID: 24108284
[TBL] [Abstract][Full Text] [Related]
4. Aneurysmal bone cyst and osteoblastoma after neoadjuvant denosumab: histologic spectrum and potential diagnostic pitfalls.
Hung YP; Bredella MA; Lobmaier IVK; Lozano-Calderón SA; Rosenberg AE; Nielsen GP
APMIS; 2022 Apr; 130(4):206-214. PubMed ID: 35114728
[TBL] [Abstract][Full Text] [Related]
5. A new computerized tomography classification to evaluate response to Denosumab in giant cell tumors in the extremities.
Campanacci L; Sambri A; Medellin MR; Cimatti P; Errani C; Donati DM
Acta Orthop Traumatol Turc; 2019 Sep; 53(5):376-380. PubMed ID: 31253385
[TBL] [Abstract][Full Text] [Related]
6. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
Yonezawa N; Murakami H; Kato S; Takeuchi A; Tsuchiya H
Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
Puri A; Gulia A; Hegde P; Verma V; Rekhi B
Bone Joint J; 2019 Feb; 101-B(2):170-177. PubMed ID: 30700112
[TBL] [Abstract][Full Text] [Related]
9. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
[TBL] [Abstract][Full Text] [Related]
10. Large sacral osteoblastoma: a case report and review of multi-disciplinary management strategies.
Khan IS; Thakur JD; Chittiboina P; Nanda A
J La State Med Soc; 2012; 164(5):251-5. PubMed ID: 23362588
[TBL] [Abstract][Full Text] [Related]
11. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
Palmerini E; Chawla NS; Ferrari S; Sudan M; Picci P; Marchesi E; Leopardi MP; Syed I; Sankhala KK; Parthasarathy P; Mendanha WE; Pierini M; Paioli A; Chawla SP
Eur J Cancer; 2017 May; 76():118-124. PubMed ID: 28324746
[TBL] [Abstract][Full Text] [Related]
12. A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab.
Yang Y; Li Y; Liu W; Xu H; Niu X
Medicine (Baltimore); 2018 Nov; 97(46):e13139. PubMed ID: 30431583
[TBL] [Abstract][Full Text] [Related]
13. An unresectable osteoblastoma of the axis controlled with denosumab.
Yamaga K; Kuwamoto S; Tanishima S; Yamashita H; Asano N; Matsushita M; Akahori K; Osaki M; Hisaoka M; Nagashima H
J Orthop Sci; 2024 Jan; 29(1):379-383. PubMed ID: 35469739
[No Abstract] [Full Text] [Related]
14. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
16. Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone.
Palmerini E; Staals EL; Jones LB; Donati DM; Longhi A; Randall RL
Curr Treat Options Oncol; 2020 Jul; 21(8):68. PubMed ID: 32623530
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic benefits of neoadjuvant and post-operative denosumab on sacral giant cell tumor: a retrospective cohort study of 30 cases.
Chen Z; Yang Y; Guo W; Yang R; Tang X; Yan T; Ji T; Xie L; Xu J; Wang J
J BUON; 2018; 23(2):453-459. PubMed ID: 29745092
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report.
Marinova VV; Slavchev SA; Patrikov KD; Tsenova PM; Georgiev GP
Folia Med (Plovdiv); 2018 Dec; 60(4):637-640. PubMed ID: 31188771
[TBL] [Abstract][Full Text] [Related]
19. Osteoblastoma-like osteosarcoma of the distal tibia.
Abramovici L; Kenan S; Hytiroglou P; Rafii M; Steiner GC
Skeletal Radiol; 2002 Mar; 31(3):179-82. PubMed ID: 11935205
[TBL] [Abstract][Full Text] [Related]
20. [Results of the treatment of osteoblastomas].
Antal I; Szendröi M
Magy Traumatol Ortop Kezseb Plasztikai Seb; 1993; 36(4):337-45. PubMed ID: 8142968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
